Category - Developments

Developments

Esperion posts positive Phase 3 bempedoic acid/ezetimibe combo results

Esperion (NASDAQ:ESPR) reported positive top-line results from a Phase 3 study of its bempedoic acid/ezetimibe combination pill for the treatment of LDL-C lowering. The study included 382 high-risk patients taking...

August 28, 2018

Developments

Sierra Oncology acquires momelotinib from Gilead

Sierra Oncology (NASDAQ:SRRA) has acquired the drug candidate, momelotinib, from Gilead Sciences (NASDAQ:GILD) for a $3-million upfront fee and potential milestone payments of up to $195-million, which are largely...

August 22, 2018

Developments

FDA accepts Evoke Pharma NDA for Gimoti; PDUFA date April 1

The FDA has accepted for review Evoke Pharma’s (NASDAQ:EVOK) 505(b)(2) NDA for Gimoti, the company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic...

August 16, 2018

Developments

electroCore in research pact with Mass General

electroCore (NASDAQ:ECOR) is collaborating with Massachusetts General Hospital (MGH) in a neuroinflammation research program. Under the program, electroCore’s non-invasive vagus nerve stimulation (nVNS) will be studied...

August 9, 2018

Developments

Growing dysphagia incidence driving development of alternative modes of drug delivery

A new study published in the peer-reviewed journal, Dysphagia, suggests that the proportion of seniors with swallowing problems in the U.S. is expected to top 20% by 2030 from 15% currently. “Dysphagia has...

August 7, 2018

Developments

Titan Pharma, Molteni amend asset, supply, support agreement

Titan Pharmaceuticals (NASDAQ:TTNP) has entered into an amendment of an earlier asset purchase, supply and support agreement with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., which allowed Molteni...

August 3, 2018

Developments

Vasomune, AnGes in pact to target vascular leakage

Closely-held Vasomune Therapeutics and AnGes (Tokyo, TYO:4563) signed a global co-development agreement for the development and commercialization of therapeutics treating diseases associated with blood vessel...

July 31, 2018

Developments

PharmaJet, Mundipharma team up to boost access to needle-free drug technology

PharmaJet and Mundipharma have inked an exclusive partnership to market and distribute PharmaJet’s Tropis and Stratis needle-free drug-delivery devices to more than 120 markets around the world. The devices are designed...

July 26, 2018

Developments

Synexus in U.S. registry study on brain ageing

Synexus, a leading global network of research sites, is collaborating with the University of Exeter in the UK to launch one of the largest, registry-based research initiatives in the U.S. to help understand how healthy...

July 25, 2018

Developments

Respinova wins Chiesi Spain and Richi Entrepreneurs second call

Israel-based Respinova has won the second grant offered by Chiesi Spain and Richi Entrepreneurs to promote an innovative project that directly impacts treatment and quality of life of patients with chronic obstructive...

July 24, 2018

Category - Developments

Subscribe